Eosinophils, found predominantly in the skin and in intestinal or respiratory mucosa, playa prominent role in parasitic infections. They are mobilized to the site of an immediate hypersensitivity reaction, where they appear to dampen or inhibit IgE mediated hypersensitivity reactions (4) . Their other actions are similar to those of neutrophils. Eosinophilia usually indicates a secondary response rather than a primary process.
Various textbooks agree that eosinophil counts below 350/mm 3 are normal and above 550/mm 3 abnormal (1); values between 350/mm 3 and 550/mm 3 appear open to interpretation. The situation is complicated because of diurnal variations, with an evening peak and a morning nadir, and because stress and exercise raise the eosinophil count. Furthermore, the usual differential smears counting 100 white blood cells introduce quite a large error when used to calculate the total eosinophil count per mrn-, These considerations are important in evaluating dialysis eosinophilia. Its definition has varied from> 3551 rnrn ' or > 5% (5) to > 400/mm 3 (3, 8) to > 450/mm 3 (15) to > 500/mm 3 (10) . Diurnal variations could explain mild eosinophilia in patients dialyzed in the evening, and the time of pre-dialysis blood sampling is not always mentioned. Using strict criteria, the true incidence of dialysis eosinophilia may not be as high as suggested, because many reported cases probably fall into the borderline zone. Nonetheless, marked elevations of over 1000/mm 3 were repeatedly present in 10% of patients according to Charytan et al. (5) . and all the reports include cases with several thousand eosinophils per mrn>. Despite some variance in definition, dialysis eosinophilia appears to be a real phenomenon.
What are the possible culprits for this phenomenon? Several renal diseases have been associated with eosinophilia. The much lower incidence of eosinophilia before the initiation of dialytic therapy, however, indicates that primary renal disease plays at best a minor role.
Dialyzer reuse might be a cause for eosinophilia, because blood products remaining in the dialyzer are altered by the sterilization with formalin and could act as an antigen or allergen. This issue was addressed by Hoy et al. (8) . who studied 36 patients before and after stopping dialyzer reuse. Six of 12 patients were cured of eosinophilia with single dialyzer use, while 3 of 24 patients newly developed eosinophilia during the same 2 months of single use dialysis. In addition, Montoliu et al. (10) has reported eosinophilia despite single dialyzer use. This would suggest that multiple dialyzer use is not the sole etiologic factor, although dialyzer reuse or sensitivity to formalin may playa role in some patients.
Ethylene oxide, now the most popular sterilization agent for dialyzers and tubings by manufacturers, may alter synthetic materials or blood components and thus stimulate allergic or immune reactions. It could thus be a cause for hemodialysis eosinophilia. In fact, anaphylactic reactions to this agent have been well described (12, 13) . Less severe reactions might present with eosinophilia but without clinical manifestations.
Elution of products from dialyzer tubings and membranes has been a concern mainly from a toxicological standpoint (9) . A report by Brommer et al. (2) has associated repeated bouts of cutaneous necrotizing dermatitis with the use of polyvinylchloride tubing. However, a correlation to any particular chemical agents such as polyvinylchloride, plasticizers, or products produced by exposure to either sterilizing agents or blood could not be established for this immunologically mediated reaction. Patterson and coworkers (11) were able to demonstrate in hemodialysis patients IgE and IgG antibodies against haptenprotein complexes prepared from chemicals used in the preparation of plastics. Thus, immunologic reactions do occur with hemodialysis, and eosinophilia may be their most common manifestation.
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The type of dialyzer was considered in several studies but appears not to have played a role in dialysis eosinophilia. The reported higher incidence with formalin sterilized reused hollow fiber artificial kidneys compared to ethylene oxide sterilized single use coils (8) is probably due to factors other than differences in dialyzer design or membrane.
While the possibility of contaminants from the dialysate or water source must also be considered, the increasing use of water treatment during the last decade and the lack of earlier reports of eosinophilia makes this an unlikely mechanism, unless agents were to be leached off the water filters and exchange resins.
Other potential treatment-related factors for eosinophilia include medications. With heparin, the most widely used drug, allergic reactions are uncommon, but have been described and may be related to a preservative (7) or a contaminant (14) . The local anesthetic used before needle insertion could account for eosinophilia due to hypersensitivity, as could other drugs, though none in particular has been implicated.
Vascular heterografts or synthetic grafts, often associated with local reactions such as rejection of bovine grafts (9) could also stimulate eosinophilia; and the increasing incidence of eosinophilia with years on dialysis (8) could reflect the more frequent use of vascular grafts after years of treatment.
Among other factors, the patient population might be a variable. In most studies, the underlying renal disease, and age or sex of patients with or without eosinophilia were not different (3, 5, 10) . Hepatitis, present in almost half of the patients of Shahin et al. (15) , could also contribute to eosinophilia. Pre-existing allergic or atopic phenomena were either absent (10) or present in some of the patients with eosinophilia (5, 8, 15) . Hoy et al. (5) found the incidence of allergic reactions significantly greater in patients with eosinophilia than in those without it.
The finding of a higher incidence of elevated IgE levels in patients with eosinophilia (3) is an intriguing observation that has since been confirmed (B.S. Spinowitz, personal communication) and strongly suggests an immunologically mediated hypersensitivity as the cause for the eosinophilia. Although the etiologic agent is yet to be found, the apparently recent occurrence of this phenomenon suggests that close attention shou Id be paid to factors that have changed in the last few years. Thus, at the present time hollow fiber dialyzers have taken a greater portion of the market. Dry sterilization with ethylene oxide is used almost exclusively, and water treatment with reverse osmosis and/or deionization is commonly employed. Some blood lines use polyurethane as an inner coating to limit the exposure to polyvinylchloride; and the use of synthetic grafts for vascular access has also increased in recent years.
What then is the clinical significance of eosinophilia? So far most patients have had no obvious symptoms, but Hoy et al. (8) have reported severe hypersensitivity reactions in two patients with eosinophilia. In another study, Charytan et al. (5) reported allergic type reactions in 5% of dialysis patients without eosinophilia, in 15% of those with intermittent eosinophilia, and in 22% of those having persistent eosinophilia. The latter group had the more serious manifestations including bronchospastic anaphylactoid reactions. Only few of the reported cases had eosinophil counts high enough to be possibly related to the hypereosinophilic syndrome with its cardiac, pulmonary, and central nervous manifestations (6) . So we are left with a new clinical problem, probably caused by hypersensitivity to several agents, and clearly the result of our ever advancing technology.
